Pharma giant Teva looks to steady ship with new CEO in coming weeks | The Times of Israel
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva expected to sell Israeli medical equipment plant for $45m
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva Pharmaceuticals resolves bribery case with Israel authorities | The FCPA Blog
Teva firing 350 employees from Israeli production facility | Ctech
EU fines Teva for allegedly delaying rollout of cheap sleep disorder drug | The Times of Israel
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) Stock Price, Quote, News & History | Nasdaq
Teva shares tumble as company faces price-fixing lawsuit - The Jerusalem Post
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
Teva to cut 14,000 jobs | Business | Chemistry World
Jewish Values Investors JLens Target Israeli Company – The Forward
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Price, Quote & News | Stock Analysis
Teva Pharmaceutical Industries Ltd Stock Price Today | TEVA Live Ticker - Investing.com
Israel's Teva Buys Allergan's Generics Business For $40 Billion | Fortune
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
Federal data reveals extent of Teva's role in fueling US opioid crisis | The Times of Israel
Why It Is Time To Load Up On Teva Stock (NYSE:TEVA) | Seeking Alpha
Teva Pharma reserves $520 million for FCPA settlement | The FCPA Blog
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Price, Quote & News | Stock Analysis
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Buy the Capitulation in Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock
Teva Recalls Drug Vials, Shuts Facility Over Mold Concerns - TheStreet
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
